A study on chronic obstructive pulmonary disease diagnosis using multilayer neural networks

A new diagnostic method for chronic obstructive pulmonary disease using the photoplethysmography signal and hybrid artificial intelligence

Background and Purpose

Chronic obstructive pulmonary disease (COPD), is a primary public health issue globally and in our country, which continues to increase due to poor awareness of the disease and lack of necessary preventive measures. COPD is the result of a blockage of the air sacs known as alveoli within the lungs; it is a persistent sickness that causes difficulty in breathing, cough, and shortness of breath. COPD is characterized by breathing signs and symptoms and airflow challenge because of anomalies in the airways and alveoli that occurs as the result of significant exposure to harmful particles and gases. The spirometry test (breath measurement test), used for diagnosing COPD, is creating difficulties in reaching hospitals, especially in patients with disabilities or advanced disease and in children. To facilitate the diagnostic treatment and prevent these problems, it is far evaluated that using photoplethysmography (PPG) signal in the diagnosis of COPD disease would be beneficial in order to simplify and speed up the diagnosis process and make it more convenient for monitoring. A PPG signal includes numerous components, including volumetric changes in arterial blood that are related to heart activity, fluctuations in venous blood volume that modify the PPG signal, a direct current (DC) component that shows the optical properties of the tissues, and modest energy changes in the body. PPG has typically received the usage of a pulse oximeter, which illuminates the pores and skin and measures adjustments in mild absorption. PPG occurring with every heart rate is an easy signal to measure. PPG signal is modeled by machine learning to predict COPD.

Methods

During the studies, the PPG signal was cleaned of noise, and a brand-new PPG signal having three low-frequency bands of the PPG was obtained. Each of the four signals extracted 25 features. An aggregate of 100 features have been extracted. Additionally, weight, height, and age were also used as characteristics. In the feature selection process, we employed the Fisher method. The intention of using this method is to improve performance.

Results

This improved PPG prediction models have an accuracy rate of 0.95 performance value for all individuals. Classification algorithms used in feature selection algorithm has contributed to a performance increase.

Conclusion

According to the findings, PPG-based COPD prediction models are suitable for usage in practice.

AI in predicting COPD in the Canadian population

Chronic obstructive pulmonary disease (COPD) is a progressive lung disease that produces non-reversible airflow limitations. Approximately 10% of Canadians aged 35 years or older are living with COPD. Primary care is often the first contact an individual will have with the healthcare system providing acute care, chronic disease management, and services aimed at health maintenance. This study used Electronic Medical Record (EMR) data from primary care clinics in seven provinces across Canada to develop predictive models to identify COPD in the Canadian population. The comprehensive nature of this primary care EMR data containing structured numeric, categorical, hybrid, and unstructured text data, enables the predictive models to capture symptoms of COPD and discriminate it from diseases with similar symptoms. We applied two supervised machine learning models, a Multilayer Neural Networks (MLNN) model and an Extreme Gradient Boosting (XGB) to identify COPD patients. The XGB model achieved an accuracy of 86% in the test dataset compared to 83% achieved by the MLNN. Utilizing feature importance, we identified a set of key symptoms from the EMR for diagnosing COPD, which included medications, health conditions, risk factors, and patient age. Application of this XGB model to primary care structured EMR data can identify patients with COPD from others having similar chronic conditions for disease surveillance, and improve evidence-based care delivery.

Analyzing the use of artificial intelligence for the management of chronic obstructive pulmonary disease (COPD)

OBJECTIVE

Chronic obstructive pulmonary disease (COPD) is a disease that causes airflow limitation to the lungs and has a high morbidity around the world. The objective of this study was to evaluate how artificial intelligence (AI) is being applied for the management of the disease, analyzing the objectives that are raised, the algorithms that are used and what results they offer.

METHODS

We conducted a scoping review following the Arksey and O'Malley (2005) and Levac et al. (2010) guidelines. Two reviewers independently searched, analyzed and extracted data from papers of five databases: Web of Science, PubMed, Scopus, Cinahl and Cochrane. To be included, the studies had to apply some AI techniques for the management of at least one stage of the COPD clinical process. In the event of any discrepancy between both reviewers, the criterion of a third reviewer prevailed.

RESULTS

380 papers were identified through database searches. After applying the exclusion criteria, 67 papers were included in the study. The studies were of a different nature and pursued a wide range of objectives, highlighting mainly those focused on the identification, classification and prevention of the disease. Neural nets, support vector machines and decision trees were the AI algorithms most commonly used. The mean and median values of all the performance metrics evaluated were between 80% and 90%.

CONCLUSIONS

The results obtained show a growing interest in the development of medical applications that manage the different phases of the COPD clinical process, especially predictive models. According to the performance shown, these models could be a useful complementary tool in the decision-making by health specialists, although more high-quality ML studies are needed to endorse the findings of this study.

Forecast the Exacerbation in Patients of Chronic Obstructive Pulmonary Disease with Clinical Indicators Using Machine Learning Techniques

Preventing exacerbation and seeking to determine the severity of the disease during the hospitalization of chronic obstructive pulmonary disease (COPD) patients is a crucial global initiative for chronic obstructive lung disease (GOLD); this option is available only for stable-phase patients. Recently, the assessment and prediction techniques that are used have been determined to be inadequate for acute exacerbation of chronic obstructive pulmonary disease patients. To magnify the monitoring and treatment of acute exacerbation COPD patients, we need to rely on the AI system, because traditional methods take a long time for the prognosis of the disease. Machine-learning techniques have shown the capacity to be effectively used in crucial healthcare applications. In this paper, we propose a voting ensemble classifier with 24 features to identify the severity of chronic obstructive pulmonary disease patients. In our study, we applied five machine-learning classifiers, namely random forests (RF), support vector machine (SVM), gradient boosting machine (GBM), XGboost (XGB), and K-nearest neighbor (KNN). These classifiers were trained with a set of 24 features. After that, we combined their results with a soft voting ensemble (SVE) method. Consequently, we found performance measures with an accuracy of 91.0849%, a precision of 90.7725%, a recall of 91.3607%, an F-measure of 91.0656%, and an AUC score of 96.8656%, respectively. Our result shows that the SVE classifier with the proposed twenty-four features outperformed regular machine-learning-based methods for chronic obstructive pulmonary disease (COPD) patients. The SVE classifier helps respiratory physicians to estimate the severity of COPD patients in the early stage, consequently guiding the cure strategy and helps the prognosis of COPD patients.

Deep learning based respiratory sound analysis for detection of chronic obstructive pulmonary disease

In recent times, technologies such as machine learning and deep learning have played a vital role in providing assistive solutions to a medical domain's challenges. They also improve predictive accuracy for early and timely disease detection using medical imaging and audio analysis. Due to the scarcity of trained human resources, medical practitioners are welcoming such technology assistance as it provides a helping hand to them in coping with more patients. Apart from critical health diseases such as cancer and diabetes, the impact of respiratory diseases is also gradually on the rise and is becoming life-threatening for society. The early diagnosis and immediate treatment are crucial in respiratory diseases, and hence the audio of the respiratory sounds is proving very beneficial along with chest X-rays. The presented research work aims to apply Convolutional Neural Network based deep learning methodologies to assist medical experts by providing a detailed and rigorous analysis of the medical respiratory audio data for Chronic Obstructive Pulmonary detection. In the conducted experiments, we have used a Librosa machine learning library features such as MFCC, Mel-Spectrogram, Chroma, Chroma (Constant-Q) and Chroma CENS. The presented system could also interpret the severity of the disease identified, such as mild, moderate, or acute. The investigation results validate the success of the proposed deep learning approach. The system classification accuracy has been enhanced to an ICBHI score of 93%. Furthermore, in the conducted experiments, we have applied K-fold Cross-Validation with ten splits to optimize the performance of the presented deep learning approach.

A telehealth system for automated diagnosis of asthma and chronical obstructive pulmonary disease

This paper presents the development and real-time testing of an automated expert diagnostic telehealth system for the diagnosis of 2 respiratory diseases, asthma and Chronic Obstructive Pulmonary Disease (COPD). The system utilizes Android, Java, MATLAB, and PHP technologies and consists of a spirometer, mobile application, and expert diagnostic system. To evaluate the effectiveness of the system, a prospective study was carried out in 3 remote primary healthcare institutions, and one hospital in Bosnia and Herzegovina healthcare system. During 6 months, 780 patients were assessed and diagnosed with an accuracy of 97.32%. The presented approach is simple to use and offers specialized consultations for patients in remote, rural, and isolated communities, as well as old and less physically mobile patients. While improving the quality of care delivered to patients, it was also found to be very beneficial in terms of healthcare.

An Expert Diagnostic System to Automatically Identify Asthma and Chronic Obstructive Pulmonary Disease in Clinical Settings

Respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD), are affecting a huge percentage of the world’s population with mortality rates exceeding those of lung cancer and breast cancer combined. The major challenge is the number of patients who are incorrectly diagnosed. To address this, we developed an expert diagnostic system that can differentiate among patients with asthma, COPD or a normal lung function based on measurements of lung function and information about patient’s symptoms. To develop accurate classification algorithms, data from 3657 patients were used and then independently verified using data from 1650 patients collected over a period of two years. Our results demonstrate that the expert diagnostic system can correctly identify patients with asthma and COPD with sensitivity of 96.45% and specificity of 98.71%. Additionally, 98.71% of the patients with a normal lung function were correctly classified, which contributed to a 49.23% decrease in demand for conducting additional tests, therefore decreasing financial cost.

A secure communication using cascade chaotic computing systems on clinical decision support

Clinical decision support systems (C-DSS) provide supportive tools to the expert for the determination of the disease. Today, many of the support systems, which have been developed for a better and more accurate diagnosis, have reached a dynamic structure due to artificial intelligence techniques. However, in cases when important diagnosis studies should be performed in secret, a secure communication system is required. In this study, secure communication of a DSS is examined through a developed double layer chaotic communication system. The developed communication system consists of four main parts: random number generator, cascade chaotic calculation layer, PCM, and logical mixer layers. Thanks to this system, important patient data created by DSS will be conveyed to the center through a secure communication line.

A clinical decision support system for femoral peripheral arterial disease treatment

One of the major challenges of providing reliable healthcare services is to diagnose and treat diseases in an accurate and timely manner. Recently, many researchers have successfully used artificial neural networks as a diagnostic assessment tool. In this study, the validation of such an assessment tool has been developed for treatment of the femoral peripheral arterial disease using a radial basis function neural network (RBFNN). A data set for training the RBFNN has been prepared by analyzing records of patients who had been treated by the thoracic and cardiovascular surgery clinic of a university hospital. The data set includes 186 patient records having 16 characteristic features associated with a binary treatment decision, namely, being a medical or a surgical one. K-means clustering algorithm has been used to determine the parameters of radial basis functions and the number of hidden nodes of the RBFNN is determined experimentally. For performance evaluation, the proposed RBFNN was compared to three different multilayer perceptron models having Pareto optimal hidden layer combinations using various performance indicators. Results of comparison indicate that the RBFNN can be used as an effective assessment tool for femoral peripheral arterial disease treatment.

Tuberculosis disease diagnosis using artificial neural networks

Tuberculosis is an infectious disease, caused in most cases by microorganisms called Mycobacterium tuberculosis. Tuberculosis is a great problem in most low income countries; it is the single most frequent cause of death in individuals aged fifteen to forty-nine years. Tuberculosis is important health problem in Turkey also. In this study, a study on tuberculosis diagnosis was realized by using multilayer neural networks (MLNN). For this purpose, two different MLNN structures were used. One of the structures was the MLNN with one hidden layer and the other was the MLNN with two hidden layers. A general regression neural network (GRNN) was also performed to realize tuberculosis diagnosis for the comparison. Levenberg-Marquardt algorithms were used for the training of the multilayer neural networks. The results of the study were compared with the results of the pervious similar studies reported focusing on tuberculosis diseases diagnosis. The tuberculosis dataset were taken from a state hospital's database using patient's epicrisis reports.

Tuberculosis disease diagnosis using artificial neural network trained with genetic algorithm

Tuberculosis is a common and often deadly infectious disease caused by mycobacterium; in humans it is mainly Mycobacterium tuberculosis (Wikipedia 2009). It is a great problem for most developing countries because of the low diagnosis and treatment opportunities. Tuberculosis has the highest mortality level among the diseases caused by a single type of microorganism. Thus, tuberculosis is a great health concern all over the world, and in Turkey as well. This article presents a study on tuberculosis diagnosis, carried out with the help of multilayer neural networks (MLNNs). For this purpose, an MLNN with two hidden layers and a genetic algorithm for training algorithm has been used. The tuberculosis dataset was taken from a state hospital's database, based on patient's epicrisis reports.